HOME     業績     Hybrid immunity from bivalent vaccination and prior infection enhances humoral and innate protection against Omicron XBB.1.16 and EG.5.1.1 variants in Japan.

業績PUBLICATION

  • Front Immunol, 17:1807238, 2026. (Jul)  
Hybrid immunity from bivalent vaccination and prior infection enhances humoral and innate protection against Omicron XBB.1.16 and EG.5.1.1 variants in Japan.
Matsuda K, Yamamoto S, Motozono C, Aritsu Y, Furukawa Y, Noborio A, Takada D, Sasagawa H, Akahori Y, Tsuchiya K, Gatanaga H, Ueno T, Ohmagari N, Mizoue T, Maeda K.